Arsenal Bio Loads Up With $325 Million Series C Funding
SOUTH SAN FRANCISCO – Arsenal Biosciences, a clinical stage programmable cell therapy company focused on…
SOUTH SAN FRANCISCO – Arsenal Biosciences, a clinical stage programmable cell therapy company focused on…
SAN FRANCISCO -- Agree, an all-in-one agreements platform that seamlessly integrates money movement, has announced…
SAN FRANCISCO -- Opkey, an Artificial Intelligence (AI) continuous test automation platform for enterprise systems, has raised…
SAN FRANCISCO -- Thatch, a personalized health benefits platform for businesses, has raised $38 million in…
PALO ALTO -- Drip Capital, a digital platform for trade finance, has secured $113 million in…
MOUNTAIN VIEW -- Codeium, an AI-powered code acceleration platform, has secured $150 million in Series…
SAN FRANCISCO --Openwater announced the acceleration of its plans to commercialize its hospital-grade technology platform…
UNION CITY -- XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for…
FREMONT – Moximed, a medical device company on a mission to improve the standard of…
SAN FRANCISCO -- Encord, an AI data development platform for advanced vision and multimodal teams,…